This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Please click here to confirm your consent. Find out more here.

International Primary Care Respiratory Group Primary Care Respiratory Society UK Primary Care Respiratory Society UK Primary Care Respiratory Society UK International Primary Care Respiratory Group Primary Care Respiratory Journal
Home
About the PCRJ
Aims, Scope and History
Editorial Board
Online first
Current Issue
education@pcrj
Past Issues
Supplements
Translations
Most popular articles
Alerts
Subscribe
Instructions for Authors
Advertising
Disclaimer and Legal Notices
Contact Us
  • Respiratory journals:
    ranked 30/50
  • Primary Health Care journals: ranked 2/17

Latest Issue – Editors’ Choice

Editors-in-Chief

Editors-in-Chief
Table of Contents PCRJ RSS Subscribe to PCRJ Current Issue Page

A new partnership with Nature Publishing Group
We are delighted to announce that, as from April 1st, the journal will be published by Nature Publishing Group (NPG). We present more detail in our editorial on pg 1.

Autoimmune disorders in parents: a risk factor for allergic disease in their children?
Autoimmune disorders and allergic diseases are characterised by increased activity of two opposing T helper cell subsets – T helper type 1 (Th1) cells in most autoimmune disorders, and T helper type 2 (Th2) cells in allergic diseases. Hitherto, these two different types of disorders were thought to be distinct and mutually exclusive. However, on pg 14, Maas et al. report their analysis of the medical records of 5,604 families in the Netherlands. The presence of any autoimmune disorder, particularly psoriasis, in fathers was associated with an increased risk of allergic disease in children, whereas in mothers, the association was restricted to rheumatoid arthritis/ankylosing spondylitis. In his thought-provoking editorial (pg 2), Weiss discusses the results and puts them into context.

Asthma comorbidities and unscheduled asthma care
Steppuhn et al. (pg 22) report the results of two consecutive national telephone surveys involving 43,312 adults in Germany. Using logistic regression models, the authors quantified the association between asthma and eight other common chronic diseases – diabetes, hypertension, chronic heart failure, depression, osteoarthritis, stroke, coronary artery disease and cancer. There was a statistically significant and independent association between asthma and all of the eight co-morbidities, particularly coronary artery disease, chronic heart failure, and stroke. 18% of people with asthma had three or more co-morbidities, and rates of unscheduled asthma care increased with the number of co-morbidities. Mercer discusses the importance of co-morbidity and multimorbidity in his linked editorial (pg 4).

GOLD ‘ABCD’ groups versus the ‘1234’ grades: impact on quality of life and costs
The rationale behind the new GOLD COPD classification into ‘ABCD’ groups is that it provides a multidimensional assessment of symptoms and exacerbation risk, unlike the old ‘1234’ grades classification which was primarily based on lung function only. The large cross-sectional study by Boland et al. on pg 30 involved a wide range of health-related quality of life (HRQoL) instruments, and is the first to compare the two different GOLD classifications in terms of healthcare costs. The GOLD ABCD groups were more strongly associated with costs and HRQoL than the old 1234 grades. Soriano and Román-Rodríguez discuss the results (pg 5) with a distinct sporting flavour…

Management of COPD in Sweden over 11 years
The extensive 11-year epidemiological study reported by Stallberg et al. (pg 38) involved patients from 76 primary healthcare centres in Sweden, corresponding to approximately 8% of the Swedish population. It provides important longitudinal data on management, co-morbidities and mortality. Incidence and prevalence rates increased over the 11-year period. The mean age at diagnosis decreased from 73 to 66 years, the number of COPD exacerbations decreased from 3.0 to 1.3 per patient per year, and hospitalisations decreased from 1.02 to 0.20 per patient per year. In their linked editorial (pg 7), Jones and Roberts discuss these results in light of the impending National COPD audit in England and Wales.

End-of-life care for advanced COPD versus lung cancer
Epiphaniou et al.’s multi-perspective, longitudinal qualitative study (pg 46) explores the difference between patients with lung cancer and those with advanced COPD in terms of their experience of the coordination of end-of-life care. They conclude that the keyworker role is of fundamental importance. LeBlanc et al. (pg 8) discuss the findings.

Primary Care Respiratory Journal will soon be re-launching as npj Primary Care Respiratory Medicine following the establishment of a new partnership with Nature Publishing Group. The journal will be online only and open access and will form part of the part of the Nature Partner Journals series. Read more at www.nature.com/npjpcrm


PROTOCOL SUMMARIES: Call for papers

The PCRJ Editors hereby invite submissions of Protocol Summary papers to be published in a new online-only section of the PCRJ from March 2013. Accepted summaries will be listed on Medline/PubMed and indexed by Thomson Reuters ISI. They will be available to readers as an open access full text manuscript free of charge.
     For all accepted Protocol Summary papers, there will be a one-off author charge of £500, payable on manuscript acceptance.

See full details as a web page or printer-friendly PDF

Online first: latest articles
PCRJ RSS Subscribe to PCRJ Online first Page

No Online first articles currently available


Latest articles in translation
1: Miravitlles M. Long-term antibiotics in COPD: more benefit than harm? Prim Care Respir J 2013;22(3):261-262. DOI: http://dx.doi.org/10.4104/pcrj.2013.00074
View article online
View full text PDF in: Spanish | Portuguese

2: James GDR, Petersen I, Nazareth I, Wedzicha JA, Donaldson GC. Use of long-term antibiotic treatment in COPD patients in the UK: a retrospective cohort study. Prim Care Respir J 2013;22(3):271-277. DOI: http://dx.doi.org/10.4104/pcrj.2013.00061
View article online
View full text PDF in: Spanish | Portuguese

3: Blakey JD, Woolnough K, Fellows J, Walker S, Thomas M, Pavord ID. Assessing the risk of attack in the management of asthma: a review and proposal for revision of the current control-centred paradigm. Prim Care Respir J 2013;22(3):344-352. DOI: http://dx.doi.org/10.4104/pcrj.2013.00063
View article online
View full text PDF in: Spanish | Portuguese

4: Sundh J, Montgomery S, Stallberg B, Lisspers K. Assessment of COPD in primary care: new evidence supports use of the DOSE index. Prim Care Respir J 2013;22(2):142-143. DOI: http://dx.doi.org/10.4104/pcrj.2013.00050
View article online
View full text PDF in: Spanish | Portuguese

5: Rolink M, van Dijk W, van den Haak-Rongen S, Pieters W, Schermer T, van den Bemt L. Using the DOSE index to predict changes in health status of patients with COPD: a prospective cohort study. Prim Care Respir J 2013;22(2):169-174. DOI: http://dx.doi.org/10.4104/pcrj.2013.00033
View article online
View full text PDF in: Spanish | Portuguese

6: Josephs LK, Coker RK, Thomas M, on behalf of the BTS Air Travel Working Group. Managing patients with stable respiratory disease planning air travel: a primary care summary of the British Thoracic Society recommendations. Prim Care Respir J 2013;22(2):234-238. DOI: http://dx.doi.org/10.4104/pcrj.2013.00046
View article online
View full text PDF in: Spanish | Portuguese

7: Fishwick D, Barber C, Walker S, Scott A. Asthma in the workplace: a case-based discussion and review of current evidence. Prim Care Respir J 2013;22(2):244-248. DOI: http://dx.doi.org/10.4104/pcrj.2013.00038
View article online
View full text PDF in: Spanish | Portuguese

Click on a flag below to view articles in the selected language.
French Greek Italian Portuguese Spanish


HTML text now available for all new articles
The PCRJ now offers full HTML text of all articles published since January 2012. Simply click on the article page and the HTML text article is immediately available. As before, the full article PDF is available free of charge to all.

Who’s citing PCRJ articles? Data from Scopus now added
New We have expanded our service showing who is citing PCRJ articles to include data from Scopus as well as CrossRef. On each article page there is a link in the right hand column: Cited by. This opens a page displaying those articles retrieved from the CrossRef database which cite the selected article. In addition, there is now a link telling you how many times the article has been cited in Scopus; up to 20 of the citing articles can then be viewed via a link to the Scopus website. For more information on CrossRef’s Cited-by Linking Service, click here. For more information on Scopus, click here.


All correspondence to:

The Editors-in-Chief
c/o Tricia Bryant, PCRS-UK Publications
Unit 2, Warwick House
Kingsbury Road
Curdworth
Sutton Coldfield
B76 9EE
UK

Telephone: +44 (0)1675 477600
Facsimile: +44 (0)121 336 1914

Email: tricia@pcrs-uk.org

The Primary Care Respiratory Society is a registered charity (Charity No: 1098117) and a company limited by guarantee registered in England (Company No: 4298947) VAT Registration Number: 866 1543 09
Registered offices and address for correspondence: Unit 2, Warwick Hosue, Kingsbury Road, Curdworth, Warwicks, B76 9EE
Telephone: +44 (0)01675 477600
Facsimile: +44 (0)121 336 1914
Email: info@pcrs-uk.org
Website: http://www.pcrs-uk.org

The Primary Care Respiratory Society UK is grateful to its corporate supporters including Almirall Ltd, AstraZeneca UK Ltd, Boehringer Ingelheim Ltd, Chiesi Ltd, GlaxoSmithKline, Napp Pharmaceuticals, Novartis UK, Orion Pharma (UK) Ltd and TEVA UK Limited for their financial support which supports the core activities of the Charity and allows the PCRS-UK to make its services either freely available or at greatly reduced rates to its members.


For information on the PCRJ complaints procedure, click here.

Website developed and maintained by danzigdesigns.com